A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
Phase of Trial: Phase II
Latest Information Update: 22 May 2017
Price : $35 *
At a glance
- Drugs ARRY 797 (Primary)
- Indications Dilated cardiomyopathy
- Focus Therapeutic Use
- Sponsors Array BioPharma
- 30 Aug 2016 Results published in Array BioPharma media release.
- 01 Jun 2016 Status changed from active, no longer recruiting to completed.
- 03 May 2016 Results from this trial will be presented at the European Society of Cardiology, according to an Array BioPharma media release.